R3i-Stiftung - Residual Risk Reduction Initiative
MevcutCH27070030171
Die Stiftung bezweckt, zur Förderung des Allgemeinwohls weltweit Anstrengungen zu unternehmen, das trotz kunstgerechter Behandlung verbleibende Restrisiko makro- und mikrovaskulärer Vorfälle bei Herz-Kreislauf- und Diabetes-Patienten zu reduzieren.
Temel Bilgiler
| Yasal Biçim | Foundation |
|---|---|
| Özet | The company's purpose is to reduce the risk of macro- and microvascular events in patients with heart, circulatory, and diabetes conditions. This suggests that the company may be involved in manufacturing medical devices or providing healthcare services. |
Adres
| Şirket Adı | R3i-Stiftung - Residual Risk Reduction Initiative |
|---|---|
| Posta Kodu | 4052 |
| Şehir | Basel |
| Kanton | Basel-Stadt |
| Ülke | Switzerland |
İş Faaliyetleri
Human Health and Social Work ActivitiesManufacturing
İletişim Bilgileri
| Web Sitesi | https://r3i.org |
|---|
Ek Bilgiler
| Kayıtlı | 20.9.2025 |
|---|---|
| Ticaret Sicili Girişi | CH27070030171 |
| Son Güncelleme | 13.12.2025 |